Literature DB >> 8396944

Molecular biology of herpes simplex virus type 1 latency in the nervous system.

I Steiner1, P G Kennedy.   

Abstract

Herpes simplex virus (HSV) is one of the best studied examples of viral ability to remain latent in the human nervous system and to cause recurrent disease by reactivation. Intensive effort was directed in recent years to unveil the molecular viral mechanisms and the virus-host interactions associated with latent HSV infection. The discovery of the state of the latent viral DNA in nervous tissues and of the presence of latency-associated gene expression during latent infection, both differing from the situation during viral replication, provided important clues relevant to the pathogenesis of latent HSV infection. This review summarizes the current state of knowledge on the site of latent infection, the molecular phenomena of latency, and the mechanisms of the various stages of latency: acute infection, establishment and maintenance of latency, and reactivation. This information paved the way to recent trials aiming to use herpes viruses as vectors to deliver genes into the nervous system, an issue that is also addressed in this review.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396944     DOI: 10.1007/bf02935640

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  136 in total

1.  Sequence of the latency-related gene of herpes simplex virus type 1.

Authors:  S L Wechsler; A B Nesburn; J Zwaagstra; H Ghiasi
Journal:  Virology       Date:  1989-01       Impact factor: 3.616

2.  Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface.

Authors:  A O Fuller; P G Spear
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

3.  Herpes simplex virus infection of the human sensory neuron. An electron microscopy study.

Authors:  E Lycke; B Hamark; M Johansson; A Krotochwil; J Lycke; B Svennerholm
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

4.  Herpes-simplex virus from trigeminal ganglion.

Authors:  S Rodda; I Jack; D O White
Journal:  Lancet       Date:  1973-06-16       Impact factor: 79.321

5.  "Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?".

Authors:  M J Ball
Journal:  Can J Neurol Sci       Date:  1982-08       Impact factor: 2.104

6.  Detection of pseudorabies virus transcripts in trigeminal ganglia of latently infected swine.

Authors:  A K Cheung
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  An in vitro latency system for herpes simplex virus type 2.

Authors:  J Russell; C M Preston
Journal:  J Gen Virol       Date:  1986-02       Impact factor: 3.891

8.  Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses.

Authors:  K D Croen; J M Ostrove; L J Dragovic; S E Straus
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Methylation of the viral genome in an in vitro model of herpes simplex virus latency.

Authors:  H Youssoufian; S M Hammer; M S Hirsch; C Mulder
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

10.  Herpes simplex virus type 1 latency-associated transcripts are evidently not essential for latent infection.

Authors:  I Steiner; J G Spivack; R P Lirette; S M Brown; A R MacLean; J H Subak-Sharpe; N W Fraser
Journal:  EMBO J       Date:  1989-02       Impact factor: 11.598

View more
  9 in total

1.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Neurovirological methods and their applications.

Authors:  P G E Kennedy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-08       Impact factor: 10.154

3.  Different modes of herpes simplex virus type 1 spread in brain and skin tissues.

Authors:  Yael Tsalenchuck; Tomer Tzur; Israel Steiner; Amos Panet
Journal:  J Neurovirol       Date:  2014-01-10       Impact factor: 2.643

4.  Recombinants are isolated at high frequency following in vivo mixed ocular infection with two avirulent herpes simplex virus type 1 strains.

Authors:  R L Kintner; R W Allan; C R Brandt
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

5.  Identification of a very early promoter of insect Hz-1 virus using a novel dual-expression shuttle vector.

Authors:  S T Lee; S M Yu; E L Hsu; Y C Chao
Journal:  Nucleic Acids Res       Date:  1995-11-25       Impact factor: 16.971

Review 6.  A comparison of herpes simplex virus type 1 and varicella-zoster virus latency and reactivation.

Authors:  Peter G E Kennedy; Joel Rovnak; Hussain Badani; Randall J Cohrs
Journal:  J Gen Virol       Date:  2015-03-20       Impact factor: 3.891

7.  Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity.

Authors:  S W Cole; B D Naliboff; M E Kemeny; M P Griswold; J L Fahey; J A Zack
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-23       Impact factor: 11.205

8.  Latent varicella-zoster virus is located predominantly in neurons in human trigeminal ganglia.

Authors:  P G Kennedy; E Grinfeld; J W Gow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-14       Impact factor: 11.205

Review 9.  Viruses, apoptosis, and neuroinflammation--a double-edged sword.

Authors:  Peter G E Kennedy
Journal:  J Neurovirol       Date:  2015-01-21       Impact factor: 2.643

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.